JPWO2021226002A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021226002A5
JPWO2021226002A5 JP2022567342A JP2022567342A JPWO2021226002A5 JP WO2021226002 A5 JPWO2021226002 A5 JP WO2021226002A5 JP 2022567342 A JP2022567342 A JP 2022567342A JP 2022567342 A JP2022567342 A JP 2022567342A JP WO2021226002 A5 JPWO2021226002 A5 JP WO2021226002A5
Authority
JP
Japan
Prior art keywords
independently
alkyl
pharma
substituted
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022567342A
Other languages
English (en)
Japanese (ja)
Other versions
JP7705884B2 (ja
JP2023524996A (ja
JP2023524996A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/030540 external-priority patent/WO2021226002A1/en
Publication of JP2023524996A publication Critical patent/JP2023524996A/ja
Publication of JPWO2021226002A5 publication Critical patent/JPWO2021226002A5/ja
Publication of JP2023524996A5 publication Critical patent/JP2023524996A5/ja
Application granted granted Critical
Publication of JP7705884B2 publication Critical patent/JP7705884B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022567342A 2020-05-05 2021-05-04 ガレクチン-3の低分子阻害剤 Active JP7705884B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063020041P 2020-05-05 2020-05-05
US63/020,041 2020-05-05
PCT/US2021/030540 WO2021226002A1 (en) 2020-05-05 2021-05-04 Small molecule inhibitors of galectin-3

Publications (4)

Publication Number Publication Date
JP2023524996A JP2023524996A (ja) 2023-06-14
JPWO2021226002A5 true JPWO2021226002A5 (https=) 2024-05-16
JP2023524996A5 JP2023524996A5 (https=) 2024-05-16
JP7705884B2 JP7705884B2 (ja) 2025-07-10

Family

ID=76076509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567342A Active JP7705884B2 (ja) 2020-05-05 2021-05-04 ガレクチン-3の低分子阻害剤

Country Status (6)

Country Link
US (1) US12275720B2 (https=)
EP (1) EP4146646A1 (https=)
JP (1) JP7705884B2 (https=)
KR (1) KR20230006547A (https=)
CN (1) CN115551855A (https=)
WO (1) WO2021226002A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2631509A (en) * 2023-07-04 2025-01-08 Univ Liverpool Compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
CN102439021B (zh) * 2009-04-28 2015-09-02 格莱克特生物技术公司 半乳凝素的新型半乳糖苷抑制剂
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
JP2015535233A (ja) 2012-10-31 2015-12-10 ガレクト・バイオテック・エイビイ ガレクチン−3のガラクトシド阻害剤及び肺線維症のためのその使用
JP6904906B2 (ja) 2015-01-30 2021-07-21 ガレクト・バイオテック・エイビイ ガレクチンの新規なガラクトシド阻害剤
ES2921500T3 (es) 2015-11-09 2022-08-26 Galecto Biotech Ab 1,1'-sulfanodiil-di-beta-d-galactopiranósidos como inhibidores de galectinas
CA3062648A1 (en) 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the prevention and treatment of diseases and the use thereof
US20200061095A1 (en) * 2017-05-12 2020-02-27 Galectin Sciences, Llc Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof
JP7190513B2 (ja) * 2018-06-15 2022-12-15 ブリストル-マイヤーズ スクイブ カンパニー ガレクチン-3抑制剤を模したテトラヒドロピラン系チオ二糖類

Similar Documents

Publication Publication Date Title
JP2020510664A5 (https=)
JP7577682B2 (ja) ガレクチン-3の低分子阻害剤
CN115734966A (zh) 杂环化合物及其用途
JP2021527102A5 (https=)
JP2019526582A5 (https=)
RU2022108080A (ru) Ингибиторы интегрина avb6
EP3793995B1 (en) Matrix metalloproteinase (mmp) inhibitors and methods of use thereof
JP2017505790A (ja) mIDH1阻害剤としてのベンズイミダゾール−2−アミン
JP2005531609A5 (https=)
JPWO2019126086A5 (https=)
JPWO2019126085A5 (https=)
JPWO2020210308A5 (https=)
WO2007002637B1 (en) N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
JPWO2021226002A5 (https=)
JPWO2020198266A5 (https=)
CN116514728A (zh) 一种喹唑啉衍生物及其用途
JPWO2021231243A5 (https=)
JP2020520388A5 (https=)
JPWO2021262812A5 (https=)
JPWO2019241461A5 (https=)
JPWO2021262810A5 (https=)
JPWO2021242982A5 (https=)
JPWO2020077123A5 (https=)
JP2021512894A (ja) 治療用化合物および組成物
JPWO2021032937A5 (https=)